| Erin Elizabeth Gratzer, MS, CCC-SLP | |
|
963 S State Road 446, Bloomington, IN 47401-8813 | |
| (812) 668-1200 | |
| Not Available |
| Full Name | Erin Elizabeth Gratzer |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 7 Years |
| Location | 963 S State Road 446, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538638614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22006915A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpro Heritage Rehab And Fitness Llc | 6507832573 | 725 |
News Archive
A preliminary, open-label study suggests that cannabidiol may be a useful adjunctive treatment in adults and children with intractable epilepsy.
Biomira Inc. has announced that the Alberta Court of Queen's Bench issued a Final Order approving the plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc.
Whitehead Institute researchers have uncovered a novel association between two fungal recognition receptors on the surface of certain immune cells, called macrophages.
Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.
› Verified 6 days ago
| Provider Name | Fox Rehab Indiana Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043568942 PECOS PAC ID: 9436303559 Enrollment ID: O20130214000146 |
News Archive
A preliminary, open-label study suggests that cannabidiol may be a useful adjunctive treatment in adults and children with intractable epilepsy.
Biomira Inc. has announced that the Alberta Court of Queen's Bench issued a Final Order approving the plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc.
Whitehead Institute researchers have uncovered a novel association between two fungal recognition receptors on the surface of certain immune cells, called macrophages.
Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.
› Verified 6 days ago
| Provider Name | Healthpro Heritage Rehab & Fitness Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1053833657 PECOS PAC ID: 6507832573 Enrollment ID: O20171009003264 |
News Archive
A preliminary, open-label study suggests that cannabidiol may be a useful adjunctive treatment in adults and children with intractable epilepsy.
Biomira Inc. has announced that the Alberta Court of Queen's Bench issued a Final Order approving the plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc.
Whitehead Institute researchers have uncovered a novel association between two fungal recognition receptors on the surface of certain immune cells, called macrophages.
Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Elizabeth Gratzer, MS, CCC-SLP 1445 Gunsmith School Rd, Bedford, IN 47421-8732 Ph: (812) 797-6525 | Erin Elizabeth Gratzer, MS, CCC-SLP 963 S State Road 446, Bloomington, IN 47401-8813 Ph: (812) 668-1200 |
News Archive
A preliminary, open-label study suggests that cannabidiol may be a useful adjunctive treatment in adults and children with intractable epilepsy.
Biomira Inc. has announced that the Alberta Court of Queen's Bench issued a Final Order approving the plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc.
Whitehead Institute researchers have uncovered a novel association between two fungal recognition receptors on the surface of certain immune cells, called macrophages.
Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.
› Verified 6 days ago
Daniel Fogerty, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 | |
Ms. Bettina R Manuel, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3021 E Tapps Turn, Bloomington, IN 47401 Phone: 812-322-7771 Fax: 812-855-5561 | |
Ms. Melanie Jill Mazur, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 S Jordan Ave, Bloomington, IN 47405 Phone: 812-855-3605 | |
Lillian Martindale, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 443 S Landmark Ave, Bloomington, IN 47403 Phone: 812-676-7000 | |
Bell Trace Health And Living Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 Fax: 812-323-2854 | |
Doreen Dotlich Devitt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 S Curry Pike, Bloomington, IN 47403 Phone: 812-330-6700 | |
Chelsea Silverman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2455 N Tamarack Trl, Bloomington, IN 47408 Phone: 812-336-7060 |